Back to results
US 6,780,620 B1Granted
Microbial transformation method for the preparation of an epothilone
AssigneeBristol-Myers Squibb Company
InventorsWenying Li, James A. Matson, Xiaohua Huang, Kin Sing Lam, Grace A. McClure
Life of this patent
Estimating the term…
Abstract
A microbial method for the preparation of an epothilone containing a terminal hydroxyalkyl group, comprising contacting at least one epothilone having a terminal alkyl group with an enzyme or microorganism capable of catalyzing the selective hydroxylation of said alkyl group to a hydroxyalkyl group, and effecting said hydroxylation.
Claims21
A method for the preparation of at least one hydroxyalkyl-bearing compound of the following formula III:
- where
- Q is selected from the group consisting of
- G1 is the following formula V
- HO—CH2—(A1)n—(Q1)m—(A2)o (V),
- where
- A1 and A2 are independently selected from the group of optionally substituted C1-C3 alkyl and alkenyl;
- Q1 is an optionally substituted ring system containing one to three rings and at least one carbon to carbon double bond in at least one ring;
- n, m, and o are integers independently selected from the group consisting of zero and 1, where at least one of m or n or o is 1;
- W is O or NR6;
- X is selected from the group consisting of O and H, OR7;
- M is O, S, NR8, or CR9R10;
- B1 and B2 are selected from the group consisting of OR11, and OCOR12;
- R1-R5 and R12-R17are selected from the group consisting of H, alkyl, substituted alkyl, aryl, and heterocyclo, and wherein when R1 and R2 are alkyl they can be joined to form a cycloalkyl;
- R6 is selected from the group consisting of H, alkyl, and substituted alkyl;
- R7 and R11 are selected from the group consisting of H, alkyl, substituted alkyl, trialkylsily, alkyldiarylsilyl, and dialkylarylsilyl;
- R8 is selected from the group consisting of H, alkyl, substituted alkyl, R13C═O, R14OC═O and R15SO2;
- R9 and R10 are selected from the group consisting of H, halogen, alkyl, substituted alkyl, aryl, heterocyclo, hydroxy, R16C═O, and R17OC═O;
- the pharmaceutically acceptable salts thereof and any hydrates, solvates, or geometric, optical and stereoisomers thereof;
- comprising the steps of contacting at least one compound of the following formula IV:
- where
- Q, W, X, M, B1, B2, and R1-R17 are as defined above;
- G2 is the following formula VI
- CH3—(A1)n—(Q1)m—(A2)o (VI),
- where A1, Q1, A2, n, m, and o are defined as above;
- the pharmaceutically acceptable salts thereof and any hydrates,solvates, or geometric, optical and stereoisomers thereof;
- with a microorganism, or P-450 enzyme isolated therefrom, said microorganism or P-450 enzyme capable of selectively catalyzing the hydroxylation of G2 to G1 and effecting said hydroxylation.
23 more elements
Dependencies are inferred from the claim text.